METTL3-mediated m6A methylation: implications for diabetes pathogenesis and therapeutic potential
- 18 September 2025
- journal article
- review article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-15
Abstract
Diabetes mellitus is a complex, chronic metabolic disease with a multifactorial pathogenesis involving genetic predisposition and environmental factors. Recently, epigenetics, particularly RNA methylation modifications, have gained increasing attention. N6-methyladenosine (m6A) is one of the most prevalent RNA modifications, and methyltransferase-like 3 (METTL3), the core component of the m6A methyltransferase complex, plays a pivotal role in regulating key physiological and pathological processes, including islet β-cell function, insulin regulation, and glucose metabolism. This article reviews the mechanisms by which METTL3 and m6A modifications contribute to the development of diabetes and its complications. Preclinical studies suggest METTL3 a promising target, but future research should focus on identifying safe, effective regulatory strategies for its clinical application. Overall, METTL3 and its m6A-mediated modifications present promising novel therapeutic targets for the prevention and treatment of diabetes mellitus, providing novel theoretical insights and strategies for managing the disease and its complications.Keywords
Funding Information
- National Natural Science Foundation of China (82170865)
- Taishan Scholar Project of Shandong Province (tsqn202211365)
This publication has 135 references indexed in Scilit:
- Diabetic retinopathy: a comprehensive review of pathophysiology and emerging treatmentsMolecular Biology Reports, 2025
- N6-methyladenosine (m6A) RNA modification in chronic myeloid leukemia: unveiling a novel therapeutic targetCellular and Molecular Life Sciences, 2024
- Inhibition of METTL3 Alleviates NLRP3 Inflammasome Activation via Increasing Ubiquitination of NEK7Advanced Science, 2024
- Global, Regional, and National Epidemiology of Diabetes in Children From 1990 to 2019JAMA Pediatrics, 2023
- METTL3 achieves lipopolysaccharide-induced myocardial injury via m6A-dependent stabilization of Myh3 mRNABiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2023
- METTL3 regulates LPS-induced inflammatory response via the NOD1 signaling pathwayCellular Signalling, 2022
- Increased m6A-RNA methylation and FTO suppression is associated with myocardial inflammation and dysfunction during endotoxemia in miceMolecular and Cellular Biochemistry, 2021
- Dysfunctional Wound Healing in Diabetic Foot Ulcers: New CrossroadsCurrent Diabetes Reports, 2018
- The Salmonella effector SopB prevents ROS-induced apoptosis of epithelial cells by retarding TRAF6 recruitment to mitochondriaBiochemical and Biophysical Research Communications, 2016
- AMP-activated protein kinase mediates effects of oxidative stress on embryo gene expression in a mouse model of diabetic embryopathyDiabetologia, 2011